Product News

What's happening at Clinly

Platform updates, milestone announcements, and notes from the team. Updated as things happen.

Latest

Platform April 2026 Live now

Clinly Platform v9 — General Availability

After two years of iterative development across nine versions, Clinly v9 is the first release we consider production-ready for real study use. This version includes the full automated protocol extraction engine, HITL review workflow, visit matrix, immutable PostgreSQL audit trail, and regulatory export engine — all tested on real protocols.

9

Major versions since 2023

12+

Real protocols validated

87.8%

First-pass extraction accuracy

The platform is available for pilot customers now. Book a demo call → Or explore the live demo →

Update history

Q1 2026

Parser March 2026

Export engine now supports Medidata Rave ALS format

Studies configured in Clinly can now be exported directly as Rave ALS (Architect Loader Spreadsheet) format, enabling CROs that run Medidata Rave as their primary EDC to use Clinly for protocol parsing and then import into their existing infrastructure.

Compliance February 2026

21 CFR Part 11 e-signature module live

Electronic signatures for CDM review actions — including HITL sign-off and data lock — are now fully implemented and aligned with 21 CFR Part 11 requirements. Each signature is cryptographically bound to its record and logged in the append-only audit trail.

Traction January 2026

First CRO pilot conversations underway

We're in active conversations with CROs about paid pilot engagements for Q2 2026. These are pre-revenue discussions — nothing signed yet — but they're based on live platform demonstrations using real protocol documents the CROs provided. See traction details →

Q4 2025

AI December 2025

Protocol parser validated on oncology, cardiology, and CNS protocols

The extraction engine was tested across therapeutic areas beyond the initial oncology focus — including cardiology (hypertension, heart failure) and CNS (depression, Alzheimer's). Accuracy held above 85% first-pass across all three areas, with CDISC domain coverage extending to MH, PR, and SU domains.

Infrastructure November 2025

Audit trail re-architected to PostgreSQL trigger level

The audit log was moved from application-level logging to PostgreSQL trigger-based enforcement. This means the application cannot suppress, modify, or delete audit entries — they're written below the application layer. A key milestone for regulatory defensibility.

Platform October 2025

v8 → v9 major rebuild: unified TypeScript backend

The backend was unified under a single Node.js/TypeScript service, replacing the fragmented v8 architecture. This enabled consistent auth middleware, structured API contracts, and a reliable foundation for the e-signature and audit trail work that followed.

Earlier milestones

Q3 2025

v7 + v8: Visit matrix visualisation, multi-arm protocol support, SDTM domain mapping expanded to 7 domains (DM, AE, VS, CM, LB, EX, DS).

Q1 2025

v5 + v6: First working extraction engine validated on a real 248-page Phase III oncology protocol. CRF library and query management system built.

Q3 2024

v3 + v4: CDISC CDASH domain structure implemented. First database schema capable of representing a real clinical trial's data model.

2023

v1 + v2: Initial concept and prototype. Identified the core problem from firsthand industry experience: EDC setup as a structural bottleneck in clinical trial startup.

Roadmap

What's Coming Next

Live milestones — updated as they happen.

Now
v9 platform — production-ready, tested on real protocols
Automated EDC with 6-format export, FDA compliance, HITL workflow
Q2 2026
First paid CRO pilot deployment
Live Phase II study on Clinly infrastructure
Q3 2026
Agentic orchestration layer (multi-agent EDC construction)
CDMs shift from builders to auditors
2027+
CTMS integration + full OSCT platform
Clinly becomes the operating system layer for clinical trials
Next Milestone
First Paid CRO Pilot — Target Q2 2026
Currently in active conversations with CROs. Platform is pilot-ready today.
days to target
View investor traction →

Stay in the loop

We send occasional updates when meaningful things happen — new features, pilot results, and honest reflections on what we're learning. No marketing drip.

Or reach us directly at hello@clinly.app